Endpoint Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Endpoint Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Endpoint Study Today - Breaking & Trending Today

FDA Issues Second Warning Letter Of 2023 Over Potentially Misleading Efficacy Claims Regarding Inhaler - Life Sciences, Biotechnology & Nanotechnology

Published: August 31, 2023

On August 15, 2023, the U.S. Food and Drug Administration (FDA) published a warning letter to AstraZeneca Pharmaceuticals LP, alleging that a professional sales brochure...

Source: mondaq.com

Related Topics:

Patrickc GallagherKellya BonnerOffice Of Prescription Drug PromotionDrug AdministrationLife SciencesTechnologies Industry GroupBreztri AerospherePrescription Drug PromotionEndpoint StudyNew England JournalMedical Technologies Industry GroupFda Issues Second Warning Letter Of 2023 Over Potentially Misleading Efficacy Claims Regarding Inhaler Life SciencesFood And Drugs LawIotechnology Amp Nanotechnology